Genomic characterisation of de novo EGFR copy number gain and its impact on the efficacy of first-line EGFR-tyrosine kinase inhibitors for EGFR mutated non-small cell lung cancer

التفاصيل البيبلوغرافية
العنوان:	Genomic characterisation of de novo EGFR copy number gain and its impact on the efficacy of first-line EGFR-tyrosine kinase inhibitors for EGFR mutated non-small cell lung cancer
المؤلفون:	Xu, Yiquan, Yan, Jingjing, Zhou, Chengzhi, Wu, Lin, Wang, Haibo, Zhao, Jun, Zhou, Maolin, Wang, Jingyi, Zheng, Xinlong, Zhang, Longfeng, Jiang, Kan, Zheng, Xiaobin, Miao, Qian, Wu, Shiwen, Zou, Zihua, lian, Rong, He, Yuange, Chen, Rongrong, Yang, Shanshan, Li, Yujing, Chen, Sihui, Lin, Gen
المصدر:	In European Journal of Cancer July 2023 188:81-89
قاعدة البيانات:	ScienceDirect

الوصف
تدمد:	09598049
DOI:	10.1016/j.ejca.2023.04.009